Stryker has completed the acquisition of Gauss Surgical, a California-based medical device company.
Kalamazoo-based Stryker said Monday, Sept. 7, it acquired Gauss, which is headquartered in Menlo Park, California, and is the developer of Triton, an artificial intelligence-enabled platform for real-time monitoring of blood loss during surgery. Triton has improved maternal and surgical care through earlier recognition of hemorrhage, leading to earlier intervention.
“Since the advent of modern surgery, visual estimation of blood loss has remained a notoriously inaccurate and imprecise standard of care,” said Siddarth Satish, CEO and founder of Gauss Surgical. “I am excited to expand this offering with Stryker.”
Studies show up to 5% of mothers will experience a post-partum hemorrhage, which is the leading cause of maternal death globally. Research also suggests 70% of these incidents are preventable, Stryker said, citing a Washington Post report. The Joint Commission revealed prevention, early recognition and timely treatment of maternal hemorrhage had the highest impact on decreasing maternal complications.
“Gauss Surgical’s innovative Triton technology will help fill the void of quantifying blood loss to enable accuracy, early detection of hemorrhage and prevention of maternal morbidity,” said Dylan Crotty, president of Stryker’s instruments division. “Our belief is that Triton technology will help improve the industry standards for quantifying blood loss in the labor and delivery department, furthering Stryker’s commitment to improve safety and outcomes for our caregivers and their patients.”
More information about Triton technology is available at safeor.com/triton.